News
CT researchers: Vaccine to fight cancer shows promise using same mRNA technology as COVID drug
The same technology that was used to create Moderna’s COVID-19 vaccine is being targeted on melanoma, and the treatment is having positive effects, according to researchers at the Yale Cancer Center.
It’s another step in using the body’s immune system to fight diseases, using a person’s own mRNA to target cancer.
The randomized Phase 2 study compares personalized mRNA vaccines given along with Keytruda, an immunotherapy drug with the generic name pembrolizumab, vs. giving Keytruda alone.
Source: The Hartford Courant